Home
Search
Search Results
Previously Searched
3096 results found
Expand All
Apply All
3096 results found

Advanced Business Development
BIO Professional Development Courses  •  June 13, 2025
Advanced Business Development (ABD) is a long-running course focusing on all key aspects of transactions in the biopharma industry. This course is ideal for professionals ranging from those with limited experience (2–3 years) looking to advance their skills; and highly experienced dealmakers or executives looking to hone their skills and network with other dealmakers. Advanced Business Development incorporates lectures from experienced dealmakers, review of example models, dissection of actual deals, interaction with other participants, and live Q&A. Also, the course includes a mock negotiation scenario when each participant is a member of a deal team assigned to negotiate a transaction involving a drug in development with another team using an actual valuation and deal structuring model.This three-day course will be held in person, June 13--15, 2025, in Boston. To add this course to your Convention registration, click the Register button.Interested in only registering for an in-person course in Boston? If you do not plan to attend the Convention but would like to register for a course only, please see the registration instructions and use the registration code provided below. COURSE-ONLY REGISTRATION INSTRUCTIONSGo to our REGISTRATION WEBSITEStart New RegistrationEnter your Email, First Name, Last Name, and Company. Select “Continue”Provide requested personal information.Enter the code STAND25 in the first “Registration Code” box and select “Apply Code.”Select “Next”Complete the required fields. Review your information on the “Review and Check Out” page and select “Next” for payment options and to complete the registration.An e-mail confirmation will be sent automatically from the registration system. Please check your email filters if you do not receive them before contacting BIO.If you have any questions about the registration process, please contact the registration team at customercare@bio.org or call …
Read More

Business Development Fundamentals
BIO Professional Development Courses  •  June 13, 2025
The Business Development Fundamentals in-person course provides a foundation of the key skills that are required to execute a licensing transaction. With a focus on the biopharma industry, the course is taught by senior executives who have personal experience and expertise in transactional and intellectual property law; business development – both sell and buy sides; finance; alliance management; negotiation, and university technology transfer.   Previous attendees include professionals from many international institutions. A sample of companies include: AlkermesNIHAmerican Society of HematologyGileadAmgenMerck National Taiwan UniversityBaylor College of MedicineNovartisBluebird BiosciencesQueensland University of TechnologyBiogenPfizerChinese University of Hong KongSanofiEli LillyTakedaEvotecUS Army Medical ResearchGenentech Who should take the course? Buy or sell-side business development or alliance management professionals with limited transactional experience Individuals interested in pursuing a career in business development, tech transfer, or alliance management Entrepreneurs Individuals who want to better understand the strategic role of business development in portfolio expansion or divestitures This three-day course will be held in person, June 13--15, 2025, in Boston, covering specific modules for each day. A case study will be distributed at the beginning of the course. To add this course to your Convention registration, click the Register button.Interested in only registering for an in-person course in Boston? If you do not plan to attend the Convention but would like to register for a course only, please see the registration instructions and use the registration code provided below. COURSE-ONLY…
Read More

BIO frequently provides webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services. Recordings of prior BIO
BIO frequently provides webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services. Recordings of prior BIO webinars are searchable below.
Read More

The Next Frontier 2025 Video Library
The Next Frontier
Nature's Building Blocks Produced for BIO by BBS StoryWroks

The Next Frontier
The Next Frontier
the_next_frontier

Path to IND for Biologics: From DNA to First-in-Human in 9 Months
Webinars  •  June 10, 2025
Join Thermo Fisher Scientific for an exclusive webinar introducing a transformative approach to biologics development and clinical scale-up. Their "Path to IND for Biologics" method accelerates the journey from DNA to IND/IMPD submission and first-in-human clinical trials in as few as 9 months. Dr. Elena Gontarz, a leading expert in the biologics industry, will guide you through this innovative process, leveraging AI/ML, transposase technology, and integrated solutions during the session: "Path to IND for Biologics: From DNA to First-in-Human in 9 Months." Following the presentation, Dr. Gontarz will answer audience questions and discuss how these novel strategies can streamline the development of complex biologics, such as Fc-fusion proteins and bispecific antibodies, driving them swiftly from development to commercialization.Get a sneak peek on this novel platform Terms and Conditions: Titer levels provided are estimates based on third party results and may vary depending on molecule type or other factors. Timeline from DNA to drug product and start of clinical trials for all path to IND for biologics options may vary depending on molecule type or other factors and are estimates to be finalized after third party cell line development dates are available and confirmed. 9-month timeline will incur additional risk.Learn more about Dr. Elena Gontarz's expertise and background:https://www.patheon.com/us/en/insights-resources/blog/navigating-the-complexities-of-process-performance-qualification.htmlhttps://www.patheon.com/us/en/insights-resources/blog/choosing-a-cdmo-who-is-a-true-bioproduction-expert.html
Read More
biotech innovation

BIO Statement on HHS Dismissal of CDC Advisory Committee Members
Press Release  •  June 9, 2025
WASHINGTON, D.C. - John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement regarding today’s dismissal of the voting members of the CDC Advisory Committee on Immunization Practices:   “The Advisory Committee on Immunization Practices (ACIP) is vital to ensuring scientific rigor and third-party experts inform decisions about the safe and effective use of vaccines in the US. Under the law, ACIP also plays a critical role determining how the American people access immunizations.  We are greatly concerned about the uncertainty created by the abrupt dismissal of the serving committee members and the loss of years of experience, especially less than three weeks before the next ACIP meeting, with consequential votes on recommendations that will affect Americans’ access to RSV, flu, HPV and other important vaccines. While the advisors serve on the ACIP at the selection and appointment by the Secretary, the removal of committee members will cause significant disruption in this critical process. Immunization reviews take place through working groups over many months, culminating with discussion during a public meeting. A wholesale change of this manner will negatively affect the Committee’s ability to deliberate and make well-informed recommendations, putting American lives at risk.   We agree that transparency is key to restoring trust in immunizations; however, the actions taken today upend a time-tested system that has protected American public health.”  ### 
Read More

Refurbished Lab Equipment & Surplus Strategy
BIO Business Solutions - Program
About ALTAmerican Laboratory Trading (ALT) is a full-service provider of premium refurbished lab equipment and surplus strategy services for the life sciences. With more than 6,000 instruments in stock ranging from small benchtop accessories to robust triple quad mass spectrometers – all items are carefully refurbished and delivered with a one-year warranty. ALT also purchases, consigns, trades, or auctions your surplus equipment to monetize your assets and maximize your ROI.
Read More

BBS Partner Resources
BIO Business Solutions
Find the latest updates on BBS program events, partner contacts, and valuable resources. For inquiries, contact dcarrillo@bio.org.
Read More

Secure File Sharing & Protection
BIO Business Solutions - Program
About ShareVaultShareVault offers secure, cloud-based document sharing solutions, also known as virtual data rooms, that are used by organizations of all types to securely share highly confidential documents with outside parties. In contrast to consumer-grade file sharing services, ShareVault allows organizations to easily share documents with third parties, while monitoring access and maintaining control.
Read More